1.05
7.89%
-0.09
前日終値:
$1.14
開ける:
$1.14
24時間の取引高:
31,484
Relative Volume:
0.57
時価総額:
$45.86M
収益:
$13.42M
当期純損益:
$-73.35M
株価収益率:
-0.5469
EPS:
-1.92
ネットキャッシュフロー:
$-56.34M
1週間 パフォーマンス:
-11.02%
1か月 パフォーマンス:
+11.70%
6か月 パフォーマンス:
-26.83%
1年 パフォーマンス:
-70.83%
Barinthus Biotherapeutics Plc Adr Stock (BRNS) Company Profile
名前
Barinthus Biotherapeutics Plc Adr
セクター
電話
44 (0) 1865 818808
住所
UNIT 6-10, ZEUS BUILDING, DIDCOT
BRNS を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
BRNS
Barinthus Biotherapeutics Plc Adr
|
1.05 | 45.86M | 13.42M | -73.35M | -56.34M | -1.92 |
VRTX
Vertex Pharmaceuticals Inc
|
407.29 | 106.10B | 10.63B | -479.80M | -1.35B | -1.99 |
REGN
Regeneron Pharmaceuticals Inc
|
700.54 | 77.86B | 13.85B | 4.65B | 3.32B | 40.41 |
ARGX
Argen X Se Adr
|
656.65 | 39.50B | 1.86B | -40.29M | -1.28B | -0.85 |
ALNY
Alnylam Pharmaceuticals Inc
|
233.72 | 30.44B | 2.09B | -332.26M | 16.06M | -2.62 |
BNTX
Biontech Se Adr
|
122.51 | 29.15B | 3.30B | -501.07M | 1.03B | -2.1146 |
Barinthus Biotherapeutics Plc Adr Stock (BRNS) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2021-05-25 | 開始されました | Jefferies | Buy |
2021-05-25 | 開始されました | Morgan Stanley | Overweight |
2021-05-25 | 開始されました | William Blair | Outperform |
2021-05-24 | 開始されました | H.C. Wainwright | Buy |
Barinthus Biotherapeutics Plc Adr (BRNS) 最新ニュース
Barinthus Bio shifts focus, cuts workforce to extend cash runway - Investing.com
New trial shows promise for chronic hepatitis B treatment - Investing.com India
Barinthus Bio completes enrollment for two clinical trials - Investing.com India
Barinthus Bio intiates Phase 1 clinical trial of VTP-1000 for treatment of coeliac disease - European Pharmaceutical Manufacturer
Barinthus Bio launches Phase 1 celiac disease therapy trial - Investing.com
Barinthus Biotherapeutics Initiates Phase 1 Clinical Trial of VTP-1000 for the Treatment of Celiac Disease - Investing.com
Barinthus Biotherapeutics appoints new COO - Investing.com
BRNS Stock Touches 52-Week Low at $1.14 Amid Market Challenges - Investing.com UK
Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket - Benzinga
Kintara Therapeutics restructures share designations By Investing.com - Investing.com
Tango Therapeutics, Inc. (TNGX) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
Spero Therapeutics, Inc. (SPRO) Q4 Earnings and Revenues Top Estimates - Yahoo Finance
Vaccitech (VACC) Stock Price, News & Analysis - MarketBeat
ADVFNFree stock and cryptocurrency prices, charts, market news and streaming real-time quotes. - ADVFN
Barinthus Biotherapeutics Plc Adr (BRNS) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):